Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorescein Angiography | 35 | 2025 | 1086 | 6.450 |
Why?
|
Tomography, Optical Coherence | 54 | 2025 | 2954 | 5.600 |
Why?
|
Visual Acuity | 36 | 2025 | 2714 | 4.210 |
Why?
|
Macula Lutea | 12 | 2025 | 180 | 3.530 |
Why?
|
Macular Degeneration | 13 | 2025 | 1015 | 3.350 |
Why?
|
Choroid | 11 | 2024 | 364 | 3.260 |
Why?
|
Retinal Pigment Epithelium | 11 | 2025 | 309 | 2.860 |
Why?
|
Retinal Vessels | 14 | 2024 | 863 | 2.830 |
Why?
|
Fundus Oculi | 16 | 2025 | 560 | 2.770 |
Why?
|
Vitelliform Macular Dystrophy | 8 | 2021 | 18 | 2.300 |
Why?
|
Retinal Drusen | 4 | 2025 | 78 | 2.190 |
Why?
|
Choroideremia | 4 | 2024 | 27 | 2.000 |
Why?
|
Choroid Diseases | 3 | 2024 | 63 | 1.590 |
Why?
|
Retinal Diseases | 7 | 2023 | 709 | 1.550 |
Why?
|
Wet Macular Degeneration | 6 | 2024 | 165 | 1.530 |
Why?
|
Fovea Centralis | 5 | 2019 | 126 | 1.220 |
Why?
|
Contrast Sensitivity | 3 | 2024 | 253 | 1.200 |
Why?
|
Choroidal Neovascularization | 10 | 2020 | 364 | 1.050 |
Why?
|
Visual Field Tests | 2 | 2025 | 415 | 0.950 |
Why?
|
Retinal Vein Occlusion | 2 | 2023 | 149 | 0.910 |
Why?
|
Retinal Perforations | 2 | 2024 | 138 | 0.860 |
Why?
|
Hemangioma, Capillary | 1 | 2023 | 64 | 0.830 |
Why?
|
Angioid Streaks | 2 | 2019 | 14 | 0.820 |
Why?
|
Retinitis Pigmentosa | 3 | 2021 | 395 | 0.810 |
Why?
|
Bruch Membrane | 2 | 2019 | 65 | 0.810 |
Why?
|
Capillaries | 4 | 2020 | 755 | 0.810 |
Why?
|
Electroretinography | 2 | 2023 | 524 | 0.800 |
Why?
|
Intravitreal Injections | 10 | 2024 | 402 | 0.780 |
Why?
|
Diabetic Retinopathy | 4 | 2024 | 1300 | 0.750 |
Why?
|
Retinal Neoplasms | 1 | 2023 | 151 | 0.740 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2023 | 566 | 0.690 |
Why?
|
Retinal Hemorrhage | 1 | 2020 | 98 | 0.670 |
Why?
|
Cerebellar Ataxia | 1 | 2021 | 151 | 0.650 |
Why?
|
Retinoschisis | 1 | 2019 | 30 | 0.650 |
Why?
|
Retinal Ganglion Cells | 2 | 2024 | 810 | 0.630 |
Why?
|
Atrophy | 4 | 2025 | 1631 | 0.610 |
Why?
|
Retina | 9 | 2024 | 2660 | 0.580 |
Why?
|
Angiogenesis Inhibitors | 10 | 2024 | 2057 | 0.530 |
Why?
|
Eye Abnormalities | 1 | 2018 | 243 | 0.510 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1326 | 0.490 |
Why?
|
Phenotype | 3 | 2023 | 16722 | 0.470 |
Why?
|
Disease Progression | 9 | 2024 | 13642 | 0.460 |
Why?
|
Optic Disk | 1 | 2018 | 421 | 0.450 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2902 | 0.430 |
Why?
|
Geographic Atrophy | 2 | 2024 | 92 | 0.430 |
Why?
|
Vision Disorders | 1 | 2019 | 1090 | 0.400 |
Why?
|
Cross-Sectional Studies | 15 | 2024 | 26309 | 0.390 |
Why?
|
Vascular Endothelial Growth Factor A | 9 | 2024 | 3511 | 0.380 |
Why?
|
Fibrosis | 3 | 2023 | 2078 | 0.370 |
Why?
|
Retinal Dystrophies | 2 | 2022 | 65 | 0.340 |
Why?
|
Wound Healing | 1 | 2021 | 2800 | 0.330 |
Why?
|
Genotype | 2 | 2023 | 13036 | 0.330 |
Why?
|
Middle Aged | 35 | 2025 | 223267 | 0.310 |
Why?
|
Ophthalmoscopy | 2 | 2019 | 172 | 0.300 |
Why?
|
Macular Edema | 3 | 2024 | 387 | 0.300 |
Why?
|
Humans | 60 | 2025 | 766812 | 0.290 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39312 | 0.290 |
Why?
|
Aged | 26 | 2025 | 171344 | 0.290 |
Why?
|
Male | 41 | 2025 | 364154 | 0.280 |
Why?
|
Young Adult | 17 | 2024 | 59939 | 0.240 |
Why?
|
Aged, 80 and over | 11 | 2024 | 59548 | 0.240 |
Why?
|
Prospective Studies | 17 | 2023 | 54872 | 0.240 |
Why?
|
Female | 38 | 2025 | 396532 | 0.230 |
Why?
|
Italy | 3 | 2022 | 856 | 0.230 |
Why?
|
Adult | 27 | 2024 | 223305 | 0.230 |
Why?
|
Vision Tests | 1 | 2023 | 160 | 0.210 |
Why?
|
Nerve Fibers | 2 | 2024 | 706 | 0.210 |
Why?
|
Adolescent | 16 | 2024 | 88902 | 0.210 |
Why?
|
Mutation | 3 | 2023 | 30214 | 0.200 |
Why?
|
Nephritis, Hereditary | 1 | 2022 | 79 | 0.200 |
Why?
|
Pseudoxanthoma Elasticum | 2 | 2018 | 14 | 0.200 |
Why?
|
cis-trans-Isomerases | 1 | 2022 | 45 | 0.200 |
Why?
|
Retrospective Studies | 11 | 2024 | 81657 | 0.180 |
Why?
|
Regional Blood Flow | 1 | 2024 | 1478 | 0.180 |
Why?
|
Microvessels | 2 | 2024 | 586 | 0.160 |
Why?
|
DNA | 2 | 2023 | 7210 | 0.160 |
Why?
|
Retinal Telangiectasis | 1 | 2019 | 26 | 0.160 |
Why?
|
Myopia, Degenerative | 1 | 2018 | 14 | 0.150 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2018 | 12 | 0.150 |
Why?
|
Quarantine | 1 | 2020 | 186 | 0.150 |
Why?
|
Child, Preschool | 7 | 2023 | 42577 | 0.150 |
Why?
|
Retinal Neurons | 1 | 2018 | 67 | 0.150 |
Why?
|
Fluorescein | 1 | 2018 | 176 | 0.150 |
Why?
|
Vitreous Body | 1 | 2019 | 401 | 0.140 |
Why?
|
Eye Infections, Viral | 1 | 2018 | 61 | 0.140 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 252 | 0.140 |
Why?
|
Child | 11 | 2023 | 80670 | 0.140 |
Why?
|
Incidence | 3 | 2023 | 21527 | 0.120 |
Why?
|
Visual Fields | 1 | 2022 | 1063 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2018 | 772 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.110 |
Why?
|
Ophthalmology | 1 | 2020 | 560 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1383 | 0.100 |
Why?
|
Disease Management | 1 | 2021 | 2533 | 0.090 |
Why?
|
Calcinosis | 1 | 2018 | 1480 | 0.080 |
Why?
|
Microscopy, Acoustic | 2 | 2018 | 47 | 0.080 |
Why?
|
Indocyanine Green | 2 | 2020 | 237 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2023 | 661 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12064 | 0.070 |
Why?
|
Coloring Agents | 2 | 2020 | 565 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40149 | 0.070 |
Why?
|
Aging | 1 | 2024 | 8728 | 0.060 |
Why?
|
Lutein | 1 | 2024 | 123 | 0.060 |
Why?
|
Retinal Neovascularization | 1 | 2024 | 287 | 0.050 |
Why?
|
Ciliary Arteries | 1 | 2020 | 19 | 0.050 |
Why?
|
Infant | 1 | 2022 | 36459 | 0.040 |
Why?
|
Cohort Studies | 1 | 2023 | 41706 | 0.040 |
Why?
|
Blood-Retinal Barrier | 1 | 2019 | 63 | 0.040 |
Why?
|
Subretinal Fluid | 1 | 2018 | 25 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 427 | 0.040 |
Why?
|
Reference Values | 1 | 2024 | 4914 | 0.030 |
Why?
|
Basement Membrane | 1 | 2017 | 348 | 0.030 |
Why?
|
Risk Factors | 1 | 2023 | 74889 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22248 | 0.030 |
Why?
|
Angiography | 1 | 2019 | 1595 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4114 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2023 | 2631 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2022 | 2744 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2614 | 0.020 |
Why?
|
Photochemotherapy | 1 | 2018 | 828 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3738 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 8065 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14762 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7240 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8728 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20146 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12985 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29959 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65286 | 0.010 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_